We are live on !
Find out more
ACM
AIGH Capital Management Portfolio holdings
AUM
$1.59B
Turnover
55.74%
1-Year Est. Return
855.46%
This Fund
S&P 500
This Quarter Est. Return
+210.96%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$1.59B
AUM Growth
+$853M
(+116%)
Cap. Flow
+$113M
Cap. Flow % of AUM
Cap. Flow %
7.13%
Top 10 Holdings %
Top 10 Hldgs %
77.96%
Holding
61
New
18
Increased
10
Reduced
16
Closed
16
Avg Time Held
Equity + Options
0.7
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.3
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$63.1M |
| 2 |
MaxLinear
MXL
|
+$57.9M |
| 3 |
Nyxoah
NYXH
|
+$38.3M |
| 4 |
Clearfield
CLFD
|
+$37M |
| 5 |
Amtech Systems
ASYS
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$72.8M |
| 2 |
Zebra Technologies
ZBRA
|
+$20.9M |
| 3 |
Tigo Energy
TYGO
|
+$19.9M |
| 4 |
nLIGHT
LASR
|
+$19.4M |
| 5 |
Generac Holdings
GNRC
|
+$17.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 52.22% |
| 2 | Miscellaneous | 30.39% |
| 3 | Healthcare | 16.81% |
| 4 | Industrials | 0.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Sandisk
SNDK
$200B
| $339M | 21.35% |
149,000
-51,000
| -26% | -$72.8M |
2025 Q3
3 quarters
|
|
2
PUT
iShares Russell 2000 ETF
IWM
$78B
| $331M | 20.89% |
1,103,000
+503,000
| +84% | +$141M |
2026 Q1
1 quarter
|
|
3
PUT
Invesco QQQ Trust
QQQ
$486B
| $142M | 8.93% |
+192,500
| New | +$132M |
2026 Q2
0 quarters
|
|
|
4
MaxLinear
MXL
$6.98B
| $105M | 6.6% |
+818,000
| New | +$57.9M |
2026 Q2
0 quarters
|
|
|
5
Intel
INTC
$499B
| $87.1M | 5.49% |
+623,500
| New | +$63.1M |
2026 Q2
0 quarters
|
|
6
Digital Turbine
APPS
$1.18B
| $84.5M | 5.32% |
6,548,450
+1,652,678
| +34% | +$9.9M |
2026 Q1
1 quarter
|
|
7
Silicon Motion
SIMO
$7.39B
| $48M | 3.03% |
144,000
-56,000
| -28% | -$13M |
2026 Q1
1 quarter
|
|
|
8
Clearfield
CLFD
$405M
| $40.1M | 2.53% |
+1,008,469
| New | +$37M |
2026 Q2
0 quarters
|
|
9
Methode Electronics
MEI
$486M
| $31.8M | 2.01% |
+1,678,409
| New | +$17.3M |
2026 Q2
0 quarters
|
|
|
10
Amtech Systems
ASYS
$229M
| $28.9M | 1.82% |
+1,252,000
| New | +$23.8M |
2026 Q2
0 quarters
|
|
11
Fennec Pharmaceuticals
FENC
$353M
| $26.7M | 1.68% |
2,486,038
+504,537
| +25% | +$4.12M |
2025 Q1
5 quarters
|
|
12
Kyverna Therapeutics
KYTX
$359M
| $24.9M | 1.57% |
2,795,797
+795,797
| +40% | +$7.06M |
2025 Q4
2 quarters
|
|
|
13
Nyxoah
NYXH
$95.9M
| $24.6M | 1.55% |
+14,534,880
| New | +$38.3M |
2026 Q2
0 quarters
|
|
14
Personalis
PSNL
$1.7B
| $23M | 1.45% |
1,715,000
-1,185,000
| -41% | -$9.6M |
2024 Q3
7 quarters
|
|
15
SOPHiA GENETICS
SOPH
$592M
| $22.8M | 1.44% |
+3,954,194
| New | +$20.1M |
2026 Q2
0 quarters
|
|
16
3D Systems Corp
DDD
$470M
| $22M | 1.38% |
+7,271,000
| New | +$19.8M |
2026 Q2
0 quarters
|
|
17
Vuzix
VUZI
$184M
| $19.6M | 1.23% |
6,745,667
+3,449,913
| +105% | +$10.9M |
2026 Q1
1 quarter
|
|
18
Abeona Therapeutics
ABEO
$256M
| $18.5M | 1.16% |
2,987,000
-113,000
| -4% | -$620K |
2025 Q4
2 quarters
|
|
19
Ardelyx
ARDX
$800M
| $16.3M | 1.03% |
+3,200,000
| New | +$19.5M |
2026 Q2
0 quarters
|
|
20
Biodesix
BDSX
$259M
| $15.3M | 0.96% |
678,328
-80,000
| -11% | -$1.19M |
2026 Q1
1 quarter
|
|
21
Spruce Biosciences
SPRB
$117M
| $13.5M | 0.85% |
+250,000
| New | +$14M |
2026 Q2
0 quarters
|
|
22
Castle Biosciences
CSTL
$997M
| $13M | 0.82% |
545,101
-45,500
| -8% | -$1.01M |
2025 Q3
3 quarters
|
|
23
Vanda Pharmaceuticals
VNDA
$247M
| $12.5M | 0.79% |
2,044,169
-705,831
| -26% | -$4.61M |
2025 Q4
2 quarters
|
|
24
Pelthos Therapeutics
PTHS
$77.2M
| $9.3M | 0.59% |
+329,098
| New | +$8.45M |
2026 Q2
0 quarters
|
|
25
CALL
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$147M
| $9.01M | 0.57% |
+2,880,000
| New | +$9.6M |
2026 Q2
0 quarters
|
|
Similar funds
AIGH Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, AIGH Capital Management held 61 positions worth $1.59B, up 116% from $733M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
AIGH Capital Management deployed $113M of net new capital in Q2 2026, opening 18 new positions and adding to 10 existing holdings. Its largest new stake was Intel: 623,500 shares worth $87.1M.
By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 35% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Sandisk, an estimated $72.8M trimmed.
- AIGH Capital Management's largest Q2 2026 buy was Intel: 623,500 shares worth $87.1M.
- AIGH Capital Management added most to Vuzix in Q2 2026, an estimated $10.9M increase.
- AIGH Capital Management's biggest Q2 2026 reduction was Sandisk, cutting an estimated $72.8M.
- AIGH Capital Management fully exited Zebra Technologies in Q2 2026, selling an estimated $20.9M.
- AIGH Capital Management's ten largest holdings make up 78% of its $1.59B portfolio in Q2 2026.
- AIGH Capital Management opened 18 new positions and closed 16 in Q2 2026.
- AIGH Capital Management's portfolio value rose 116% quarter-over-quarter to $1.59B.
Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.